Weiss Amir 4
4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Dec 18, 2025
Insider Transaction Report
Form 4
Weiss Amir
Chief Accounting Officer
Transactions
- Sale
Ordinary Shares
2025-12-16$30.20/sh−12,300$371,504→ 5,650 total
Footnotes (2)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.20 to $30.205, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.